Skip to content

RELiZORB 100300/100301

by Alcresta Therapeutics, Inc.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

None found

in data synced 22 Oct 2026

Documents

None

No authorization documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source GUDID, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00862205000250 UDI-DI Date8 May 2024ListedStatusListed GUDID: in commercial distribution

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade Name
RELiZORB
Generic Name
Enteral feed fat-digestion cartridge
Model / Reference
100300/100301
Primary DI / UDI-DI
00862205000250
510(k) Number
FDA Product Code
PLQ
GMDN Term
Enteral feed fat-digestion cartridge
Device Class
Class II
Regulation Number
876.5985
GUDID distribution status
In Commercial Distribution

Related devices

Category: Enteral feed fat-digestion cartridge

Similar devices

Also classified as Enteral feed fat-digestion cartridge.

Other devices from Alcresta Therapeutics, Inc.

See all devices from Alcresta Therapeutics, Inc. →

Properties

  • Single Use
  • Prescription Use
  • Lot / Batch Number
  • Expiration Date

Other properties (10)

  • Sterile: No
  • Implantable: No
  • Contains Latex: No
  • Over-the-Counter: No
  • Convenience Kit: No
  • Combination Product: No
  • HCT/P: No
  • Premarket Exempt: No
  • Serial Number: No
  • Manufacturing Date: No